First structure-activity relationship study on dopamine D3 receptor agents with N-[4-(4-Arylpiperazin-1-yl)butyl]-arylcarboxamide structure

Journal of Medicinal Chemistry

Volumn 48, Issue 25, 2005, Pages 7919-7922

  Leopoldo, Marcello ^a   Lacivita, Enza ^a   Colabufo, Nicola A ^a   Contino, Marialessandra ^a   Berardi, Francesco ^a   Perrone, Roberto ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,3 DICHLOROPHENYL)PIPERAZINE DERIVATIVE; DOPAMINE 3 RECEPTOR BLOCKING AGENT; DOPAMINE 3 RECEPTOR STIMULATING AGENT; N [4 (4 PIPERAZIN 1 YL)BUTYL]CARBOXAMIDE DERIVATIVE; N [4 [2 (6 CYANO 1,2,3,4 TETRAHYDRO 2 ISOQUINOLINYL)ETHYL]CYCLOHEXYL] 4 QUINOLINECARBOXAMIDE; SB 414796; UNCLASSIFIED DRUG;

ARTICLE; DRUG STRUCTURE; RECEPTOR BINDING; RECEPTOR INTRINSIC ACTIVITY; STRUCTURE ACTIVITY RELATION;

AMIDES; ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; HUMANS; PIPERAZINES; RADIOLIGAND ASSAY; RECEPTORS, DOPAMINE D3; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 29144441068     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm050729o     Document Type: Article

References (22)

1. 3 dopamine receptor: neurobiology and potential clinical relevance. Pharmacol. Rev. 1997, 49, 231-252.
2. Biglan, K. M.; Holloway, R. G. A review of pramipexole and its clinical utility in Parkinson's disease. Expert Opin. Pharmacother. 2002, 3, 197-210.
3. 3) as a target of neuroleptics. Nature 1990, 347, 72-76.
4. 3 receptors in drug addiction: a review of pharmacological evidence. Brain Res. Rev. 2005, 49, 77-105.
5. Beardsley, P. M.; Sokoloff, P.; Balster, R. L.; Schwartz, J. C. The D3R partial agonist, BP 897, attenuates the discriminative stimulus effects of cocaine and D-amphetamine and is not self-administered. Behav. Pharmacol. 2001, 12, 1-11.
6. 3 receptor agonist. Nature 1999, 400, 371-375.
7. 3 dopamine receptor ligands as potential therapeutic agents for neurological and neuropsychiatric disorders. Curr. Pharm. Des. 2003, 9, 643-671.
8. 3 receptor ligands with antagonistic properties. ChemBioChem 2002, 3, 946-961.
9. 3 receptor ligands. J. Med. Chem. 2002, 45, 5727-5735.
10. 3 receptor antagonists. Bioorg. Med. Chem. Lett. 1998, 8, 2715-2718.
11. 3 receptor subtype. J. Med. Chem. 2001, 44, 3175-3186.
12. 2 receptors. J. Med. Chem. 2003, 46, 3822-3839.
13. 3 receptor antagonists and partial agonists. J. Med. Chem. 2002, 45, 4594-4597.
14. 3 receptor ligands. J. Med. Chem. 2003, 46, 3883-3899.
15. 3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents. J. Med. Chem. 2005, 48, 3663-3679.
16. Frang, H.; Mukkala, V.-M.; Syystö, R.; Ollikka, P.; Hurskainen, P.; Scheinin, M.; Hemmilä, I. Nonradioactive GTP binding assay to monitor activation of G protein-coupled receptors. Assay Drug Dev. Technol. 2003, 1, 275-280.
17. Wicke, K.; Javier Garcia-Ladona, J. The dopamine D3 receptor partial agonist, BP 897, is an antagonist at human dopamine D3 receptors and at rat somatodendritic dopamine D3 receptors. Eur. J. Pharmacol. 2001, 424, 85-90.
18. Zimmerman, H. E.; Giallombardo, H. J. The stereochemistry of the ketonization reaction of enols. III. J. Am. Chem. Soc. 1956, 78, 6259-6265.
19. Johnson, W. S.; Offenhauer, R. D. 4-(p-Hydroxyphenyl)- hexahydroacetophenone and homologues. J. Am. Chem. Soc. 1945, 67, 1045-1049.
20. de Meglio, P.; Ravenna, F.; Carenini, G.; Gentili, P.; Manzardo, S.; Tempra Gabbiati, G.; Riva, M. Derivati della 4-fenilcicloesiletilammina ad attività antidepressiva. Farmaco Ed. Sci. 1982, 37, 836-858.
21. 1A and D-2 receptor affinity of o-methoxyphenylpiperazine derivatives with terminal benzamide fragment on N-4 alkyl chain. 2. Farmaco 1995, 50, 505-510.
22. 3 receptors in Chinese hamster ovary cells. J. Pharmacol. Exp. Ther. 1999, 290, 908-916.